Overview

KJ-TFC-004 Drug-drug Interaction Study

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetic Interaction between Dorzolamide and Brimonidine in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Kukje Pharma
Treatments:
Brimonidine Tartrate
Dorzolamide
Ophthalmic Solutions
Tetrahydrozoline
Timolol